Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.600 | None | 1.000 | 9 | 0 | 2002 | 2020 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
disease | 0.600 | None | 0.956 | 8 | 0 | 1996 | 2020 | ||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
disease | 0.600 | None | 0.966 | 6 | 0 | 1995 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.600 | None | 0.957 | 4 | 0 | 1997 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.600 | None | 0.917 | 1 | 0 | 2005 | 2019 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.400 | None | 1.000 | 6 | 0 | 1998 | 2020 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 1 | 0.610 | 0.615 | 1.3E-04 |
|
disease | 0.400 | None | 0.786 | 2 | 0 | 2001 | 2018 | ||||||||
|
nuclear receptor subfamily 5 group A member 1 | 0.479 | 0.731 | 0.99 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.380 | None | 0.889 | 1 | 0 | 1994 | 2019 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 2 | 0.656 | 0.385 | 1.8E-10 |
|
disease | 0.370 | None | 1.000 | 2 | 0 | 2002 | 2020 | ||||||||
|
insulin like growth factor binding protein 1 | 0.502 | 0.808 | 9.5E-04 |
|
disease | 0.360 | None | 1.000 | 1 | 0 | 2003 | 2012 | ||||||||
|
interleukin 15 | 0.422 | 0.846 | 0.71 |
|
disease | 0.350 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
interleukin 1 receptor type 1 | 0.509 | 0.769 | 0.15 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2004 | 2011 | ||||||||
|
aryl hydrocarbon receptor nuclear translocator | 0.575 | 0.692 | 1.00 |
|
disease | 0.330 | None | 0.750 | 1 | 0 | 2002 | 2015 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2008 | 2013 | ||||||||
|
C-C motif chemokine ligand 1 | 0.587 | 0.692 | 8.0E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
lactotransferrin | 0.543 | 0.846 | 1.3E-21 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2011 | ||||||||
|
tenascin C | 0.433 | 0.846 | 1.3E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2011 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.300 | None | 0.932 | 12 | 0 | 1999 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.300 | None | 0.963 | 7 | 0 | 2002 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.300 | None | 0.931 | 6 | 0 | 2002 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.300 | None | 0.936 | 6 | 0 | 2000 | 2019 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.280 | None | 1.000 | 2 | 0 | 1997 | 2019 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2008 | 2016 |